None
Quote | Immupharma PLC (OTCMKTS:IMMPF)
Last: | $0.085 |
---|---|
Change Percent: | 6.25% |
Open: | $0.08 |
Close: | $0.085 |
High: | $0.085 |
Low: | $0.08 |
Volume: | 20,500 |
Last Trade Date Time: | 04/19/2022 04:53:08 pm |
News | Immupharma PLC (OTCMKTS:IMMPF)
(NewsDirect) ImmuPharma PLC (AIM:IMM) chief executive Tim McCarthy provides an extensive update during an interview with Proactive's Stephen Gunnion, focusing on the financial, business, and portfolio developments of the company. McCarthy clarified that the company is in a strong fina...
(NewsDirect) ImmuPharma PLC (AIM:IMM, OTC:IMMPF) chief executive Tim McCarthy visited Thomas Warner at the Proactive London studio after confirming to the market that the specialty biopharmaceutical will be moving forward into a key phase 2/3 adaptive clinical trial, alongside its US part...
Message Board Posts | Immupharma PLC (OTCMKTS:IMMPF)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Immupharma PLC Company Name:
IMMPF Stock Symbol:
OTCMKTS Market:
(NewsDirect) ImmuPharma PLC (AIM:IMM) chief executive Tim McCarthy provides an extensive update during an interview with Proactive's Stephen Gunnion, focusing on the financial, business, and portfolio developments of the company. McCarthy clarified that the company is in a strong fina...
(NewsDirect) ImmuPharma PLC (AIM:IMM, OTC:IMMPF) chief executive Tim McCarthy visited Thomas Warner at the Proactive London studio after confirming to the market that the specialty biopharmaceutical will be moving forward into a key phase 2/3 adaptive clinical trial, alongside its US part...
(NewsDirect) Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com Copyright (c) 2023 TheNewswire - All rights reserved.